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Abstract
Background Diagnosis and treatment of low-grade
chondrosarcoma remain controversial. We performed a
review of a single-center series with the aims of assessing
the oncologic outcome of these patients, verifying if int-
ralesional curettage can be adequate treatment, and defining
clinical criteria to support the surgeon and the oncologist in
decision-making for surgery and subsequent follow-up.
Materials and methods A retrospective review of 85
patients was performed (61 females and 24 males, age
range 20–76 years). The site of the lesion was the femur in
35 cases, humerus in 33, tibia in 15, and fibula in 2. Sixty-
four patients were treated by intralesional curettage.
Twenty-one patients with aggressive radiological patterns
were treated with wide resection.
Results Mean follow-up was 67 months (range 24–206
months). Two patients developed local recurrence, both
after intralesional curettage. The difference in incidence of
recurrence was not statistically significant between the two
groups. No distant metastases were observed. Postsurgical
complications were significantly higher in the resection
group.
Conclusions Low-grade chondrosarcoma of the appen-
dicular skeleton without aggressive radiological patterns
can be treated with intralesional surgery with good
oncological outcome and very low rate of postsurgical
complications. Wide resection, following surgical princi-
ples of malignant bone tumors, should be considered only
when aggressive biologic behavior is evident on imaging.
Keywords Chondrosarcoma  Bone sarcoma 
Bone tumors  Orthopedic oncology
Introduction
Chondrosarcoma (CS) is the second most frequent primary
malignant bone tumor after osteosarcoma. Central CS may
grow primarily in the medullary canal of healthy bone or
may be secondary to pre-existing benign enchondroma [1].
The prognosis of central CS is directly correlated with the
histological grade of malignancy, which is assessed fol-
lowing the criteria described by Evans et al., considering
cellularity, tumor matrix characteristics, nuclear features,
and mitotic rate [2]. Histologic evaluation of cartilaginous
tumors represents a challenging task for the pathologist,
and consistent interobserver variability, concerning grading
and the distinction between benign and malignant lesions,
was observed [3, 4]. Moreover, in the past the concept of
‘‘borderline’’ lesion was introduced, with the aim of indi-
cating a cartilaginous lesion more active than a benign
enchondroma but less atypical than a grade 1 chondrosar-
coma [5]. Other definitions were used to indicate borderline
lesions, such as ‘‘atypical enchondroma,’’ ‘‘grade 0 chon-
drosarcoma,’’ and ‘‘cartilaginous lesion with unknown
malignant potential’’ (CLUMP) [6, 7], but finally there was
no common agreement on the adequacy and usefulness
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of these definitions, which have now generally been
abandoned.
In cartilaginous tumors, biopsy can confirm the diag-
nostic hypothesis of cartilaginous lesion without being
reliable in grading the tumor, since different areas with
progressive grade of malignancy can be found within the
same lesion and benign enchondroma may coexist with an
area of dedifferentiation in a highly malignant tumor. For
this reason, clinical and imaging criteria must be consid-
ered in decision-making regarding the surgical approach to
low-grade chondrosarcoma.
Cartilaginous tumors of the appendicular skeleton have
shown less aggressive biologic behavior than axial tumors
[8–11], and good local control of the tumor with excellent
long-term survival was obtained with both intralesional
surgery and segmental resection in grade 1 CS of the
appendicular skeleton [11–17]. Nevertheless, local recur-
rence of grade 1 CS may present a progression of malig-
nancy with an influence on patient survival [18]. In recent
decades, intralesional curettage with local adjuvants and
bone filling with either bone grafts or cement has been
widely used as surgical treatment of grade 1 CS of the
appendicular skeleton [12, 15–17, 19–22]. On the other
hand, in case of an aggressive aspect on imaging and cor-
tical disruption of grade 1 CS, resection with wide margins,
following the surgical criteria of primary bone sarcoma, has
been recommended [5, 6, 13, 14, 23, 24]. We reviewed our
experience of surgical treatment of central grade 1 CS of
the appendicular skeleton with the aim of assessing the
oncologic outcome of these patients, verifying if intrale-
sional curettage can be adequate treatment, and defining
clinical criteria to support the surgeon and oncologist in
decision-making for surgery and subsequent follow-up.
Materials and methods
A retrospective review of patients treated in authors’
institution for central grade 1 chondrosarcoma of long
bones from 1994 to 2010 was performed. Ninety-nine
patients meeting the above-mentioned criteria were iden-
tified. Fourteen patients were excluded from the present
study due to follow-up of less than 24 months or insuffi-
cient clinical or radiological data. Eighty-five patients
remained for evaluation. There were 61 females and 24
males with mean age of 50 years (range 20–76 years). The
site of the lesion was the femur in 35 cases, humerus in 33,
tibia in 15, and fibula in 2 cases.
All patients with definitive histological diagnosis of
central grade 1 CS on analysis of the entire specimen were
included in the present study. Histological diagnosis of
grade 1 CS was done according to established criteria
reported in the literature [3, 4, 25].
The need for informed consent was waived by the eth-
ical committee since rights and interests of the patients
would not be violated and their privacy and anonymity
would be ensured by the study design. The research con-
formed to the Declaration of Helsinki.
Imaging features of the lesion were considered in sur-
gical treatment planning. Evidence of bone enlargement
with cortical thinning or thickening and/or interruption,
periosteal reaction, or presence of soft tissue mass led us to
choose segmental resection with tumor-free margins
(Fig. 1). In absence of the above-mentioned criteria of
aggressiveness, in case of intraosseous cartilaginous lesion
with mild or moderate endosteal cortical scalloping, int-
ralesional curettage was performed (Fig. 2).
In 64 cases (75.3 %) intralesional curettage was per-
formed using phenol and alcohol as local adjuvants in
69 % of cases. The defect was filled with allogenic bone
chips in 60 cases; bone cement was employed to fill the
defect in 3 cases, while in 1 patient a bone substitute was
used. Prophylactic internal fixation was performed with
plate in 16 patients.
Twenty-one patients (24.7 %) underwent segmental
resection with wide surgical margins. Reconstruction was
performed using a modular endoprosthesis in six cases,
massive allograft in four cases (allograft alone in one case,
osteoarticular allograft ? vascularized fibular autograft in
two cases, intercalary allograft ? vascularized fibular
autograft in one case), and an allograft–prosthetic com-
posite in five cases (in one of these patients, total tibia
resection was performed since he had been treated in
another hospital with intramedullary locked nail fixation
for a pathological fracture on a central grade 1 CS of the
tibia with consequent contamination of the entire tibia; in
this patient a long-stem rotating-hinge prosthesis was
cemented into a total tibia massive allograft). In three
patients, the resected intercalary segment was curetted on a
separate table, sterilized by autoclave, and reimplanted
combined with a vascularized fibular autograft in two cases
and filled with cement in another patient. A vascularized
fibular autograft alone was employed in two cases. In one
case no reconstruction was performed (fibula).
All patients were clinically and radiologically evaluated
at last follow-up, except for five patients who had been
followed up by local orthopedic surgeons and did not come
back to our unit. These patients were interviewed by phone,
and the latest radiographic evaluation was adopted for
oncological status and date of latest follow-up.
Results
At average follow-up of 67 months (range 24–206 months),
two patients had developed local recurrence and no distant
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metastases were observed. One of the local recurrences
occurred in a 71-year-old man after intralesional curettage
of a grade 1 CS of the distal tibia. The patient was tem-
porarily lost to follow-up but after 3 years from surgery he
came back with extensive local recurrence involving the
distal third of the tibia and presenting soft tissue extension.
The patient refused the proposed below-knee amputation
and underwent distal tibia resection and reconstruction
with ankle arthrodesis using allogenic cortical struts, bone
autograft from iliac crest, and intramedullary anterograde
locked nail fixation. Final histologic response on the
resected specimen demonstrated marginal surgical margins
and progression of malignancy in grade 2 CS. The patient
required a secondary soleal rotational flap coverage for
wound dehiscence and eventually developed a deep
infection, finally treated by below-knee amputation. The
second recurrence occurred 2 years after curettage and
bone grafting of a lesion involving proximal fibula; the
patient was treated with proximal fibula resection at
another institution, and grade 1 was confirmed at histologic
examination.
Both recurrences occurred after curettage (3.1 % of
cases treated with this method); no recurrences were
observed after resection. The difference between the two
groups was not statistically significant according to Fisher’s
exact test (P = 1.0).
After intralesional curettage (64 patients) a pathologic
fracture of the femur was observed in 1 case (1.6 %). The
fracture healed after conservative treatment.
Segmental resection was performed in 21 patients, and
in 6 cases (28.6 %) a complication was observed, requiring
surgical revision in 5 cases. In one patient with distal femur
modular prosthesis, stem breakage occurred and conver-
sion to total femur prosthesis was performed. Dislocation
of an allograft reverse-prosthetic composite of the proximal
humerus was observed in one case. One patient with an
allograft–prosthetic composite of the proximal femur
developed allograft resorption and acetabular erosion due
to the bipolar prosthetic head; the allograft was removed
and replaced with a modular prosthesis, and an acetabular
cemented component was implanted. Two patients, treated
with osteoarticular allograft of the proximal humerus
associated with vascularized fibular autograft, sustained
fracture of the allograft with collapse of the articular sur-
face; the allograft was removed in both cases and replaced
by a modular prosthesis in one case and by an allograft
reverse-prosthetic composite in one case. In one case,
stress fracture of the vascularized fibular graft after inter-
calary resection of the humerus was seen to heal sponta-
neously with conservative treatment.
No deep infections occurred besides the above-men-
tioned case after second surgery.
Fig. 1 a, b Grade 1 CS of the proximal tibia involving the whole
metaepiphysis. The anteroposterior (AP) radiographic view and
magnetic resonance imaging (MRI) show the endosteal scalloping
and cortical thinning consistent with aggressive imaging features.
c, d Proximal tibia resection with wide margins and allograft–
prosthesis composite reconstruction was performed
Fig. 2 a Grade 1 CS of the distal femur. MRI lateral view. b Positive positron emission tomography (PET) scan. c, d AP and lateral (LL)
radiographs at 5.5 years from surgery. Curettage, filling with allografts, and plate and screws fixation were performed
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The incidence of complications was significantly higher
in the resection group (Fisher’s exact test: 0.0007).
Discussion
Surgical treatment of low-grade central CS has been a
subject of debate for a long time. Some authors advocate
wide resection margins, while others consider intralesional
curettage sufficient for adequate local control [11–24]. This
discordance is probably favored by two factors: interob-
server variability in histologic diagnosis of cartilaginous
tumors (overgrading of atypical enchondroma and under-
grading of grade 2 chondrosarcoma) and inclusion of both
appendicular and axial skeleton lesions in some of the
reported series.
Central CS of the axial skeleton showed more aggres-
sive biologic behavior than appendicular tumors, and high
incidence of local recurrence after intralesional excision of
grade 1 CS of the axial skeleton was reported [5, 9, 10, 24].
Conversely, in the appendicular skeleton, excellent local
control and survival were reported after intralesional
curettage of grade 1 CS [12, 15–17, 19–21]. Therefore,
axial and appendicular lesions should be evaluated sepa-
rately, as in this study.
The variability in histological grading and the conse-
quent bias, which impacts on every work on this subject, is
more difficult to overcome. Different imaging techniques
or clinical patterns have been tested and proposed to sup-
port the diagnosis, but no conclusive data are currently
available. In fact, a variable spectrum of imaging pat-
terns can be associated with grade 1 CS, ranging from
apparently benign asymptomatic enchondroma to clearly
aggressive symptomatic malignant cartilaginous lesion.
Lesion dimensions were argued to be indicative of malig-
nancy, but this was not confirmed by recent investigations
[14]. Cortical bone alterations such as endosteal scalloping,
thinning, thickening, bone enlargement, and cortical
interruptions or periosteal reaction were considered signs
of malignancy, and computed tomography (CT) scan is the
best option to evaluate cortical bone modifications. Bone
enlargement and cortical thinning were found to be sig-
nificant signs of malignancy in a recent report, and the
authors suggested wide resection as surgical treatment
when these imaging features are observed [14]. The pres-
ence of soft tissue mass represents another important sign
of malignancy; in a recent investigation about MRI find-
ings in these tumors, the authors concluded that soft tissue
mass was indicative of high-grade lesion whereas the
presence of entrapped fat within the tumoral tissue was
consistent with low-grade tumors [26]. Dynamic MRI was
found useful in differential diagnosis between benign and
malignant cartilaginous lesions; early uptake of gadolinium
with an exponential curve was associated with malignant
cartilaginous tumors [27]. Recently, the role of fluorode-
oxyglucose positron emission tomography in differential
diagnosis of cartilaginous tumors was investigated: the
standard uptake value resulted to be correlated to the grade
of malignancy, with a cutoff value between benign and
malignant lesions ranging from 2 to 2.3 in two different
reports, with statistical significance in only one of them
[28, 29].
It is commonly accepted that the diagnostic approach to
central low-grade CS must be multidisciplinary, requiring a
trained and experienced team of radiologists, pathologists,
oncologists, and surgeons.
In our opinion, small (\5 cm), asymptomatic, intraos-
seous cartilaginous lesions of long bones with absence of
radiological and MRI signs of local aggressiveness should
be observed as benign enchondroma, and no surgery or
further investigations other than serial radiological follow-
up are indicated.
In larger and/or symptomatic lesions, dynamic MRI or
PET scan is indicated. If the adopted examination is neg-
ative, conservative monitoring of the lesion is the treatment
of choice, unless the site and/or size of the lesion warrant
surgical intervention with intralesional curettage and fill-
ing. If dynamic MRI or PET scan (SUV [2) is positive, a
diagnosis of low-grade chondrosarcoma is to be assumed
and decision-making on surgical treatment should be done
considering imaging aspects, because histologic diagnosis
of cartilaginous tumors requires analysis of the entire
specimen and a biopsy sample is not enough for grading
(progression of malignancy may be present, and in the
same lesion different areas of benign enchondroma and
malignant chondrosarcoma may coexist).
Grade 1 CS of the appendicular skeleton with no
aggressive imaging features can be treated with intrale-
sional curettage and local adjuvants. However, when
aggressive biologic behavior is evident on imaging, seg-
mental resection following surgical principles of malignant
bone tumors seems more appropriate.
In our protocol, biopsy was omitted in cartilaginous
lesions without radiographic aggressive behavior, and
definitive histologic diagnosis was made on the entire tis-
sue obtained by curettage. When an aggressive imaging
pattern was evident, biopsy was performed to confirm
diagnosis before resection. Since definitive diagnosis is
possible only after examination of the complete specimen,
the chance of inadvertent curettage of grade 2 CS must be
considered, but after secondary appropriate treatment with
wide resection, no adverse influence on outcome was
reported [30]. Our personal therapeutic opinion was vali-
dated by the results of the present study: in our series, by
accurate selection of patients based on imaging criteria, no
inadvertent curettage of grade 2 CS was observed.
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Nonetheless, this possibility should always be considered,
and adequate surgical exposure and technique must always
be adopted to make a second procedure of wide resection
feasible.
After intralesional curettage, local adjuvants on the
cavity walls can be used to decrease the risk of local
recurrence, although no definitive data are available to
support this choice. Phenol plus ethanol [13, 14, 16] and
cryosurgery [14–16, 20–22, 31] have been used as local
adjuvants in curettage of central low-grade CS, and no
significant difference in local control was observed between
these different techniques. From previous in vitro studies,
phenol appeared to be ineffective on cartilaginous tissue
and protective properties of chondroid matrix against the
cytotoxic action of phenol had been postulated [32]. On
the contrary, recent investigations demonstrated in vitro the
cytotoxic effect of phenol and ethanol on chondrosarcoma
cells at minimum concentration of 1.5 % and 42.5 %,
respectively [33]. Cryosurgery may be performed with
liquid nitrogen, directly poured into the cavity, or
employing cryoprobes using liquid nitrogen or argon gas.
Cryotherapy induces deep necrosis (7–12 mm), and pro-
phylactic internal fixation was recommended to decrease
the risk of pathologic fracture [34]. After curettage, the
bone cavity may be filled by bone grafts (autologous or
allogenic) [13, 14, 16, 21, 31] or methylmethacrylate
[10, 13, 14, 16, 17, 20–22], or may be left empty [14, 15]. Bone
cement is also considered a local adjuvant due to the necro-
tizing effect of the exothermic reaction on the cavity wall.
According to the above-mentioned criteria, in our series
of 85 cases of low-grade chondrosarcomas, we could per-
form conservative surgery (curettage and filling) in 64
patients, with only two cases of local recurrence. The
results of treatment in our series confirm that low-grade
chondrosarcoma has favorable prognosis with low rate of
local recurrence and low or null rate of distant metastasis.
This is in accordance with data reported by other authors
after both intralesional curettage and segmental resection
(Table 1).
Leerapun et al. [13], in a series of 70 patients treated
with intralesional curettage in 13 cases and segmental
resection in 57 cases, reported one local recurrence in each
group of patients and no differences in survival. The
authors concluded that intralesional curettage should be
reserved for central grade 1 CS of long bones without
aggressive imaging features such as soft tissue mass and
cortical disruption. A similar conclusion was reached by
Donati et al. [14], who reported 31 cases of central grade 1
CS of long bones with long-term follow-up (mean
157 months, minimum 66 months), treated with curettage
in 15 cases and resection in 16 cases. Two local recur-
rences were observed in the curettage group, and bone
enlargement and cortical thinning were imaging features
strongly indicative of higher biological aggressiveness of
the tumor. No difference in local recurrence rate between
curettage and segmental resection of central grade 1 CS of
long bones was reported also by Aarons et al. [16], and
lower complication rate and better functional outcome
were observed after intralesional surgery.
According to these data, the complication rate in our
series is consistently higher after segmental resection
(28.6 %) than after intralesional curettage (1.6 %). Local
recurrence occurred only after curettage in our series, but
with a very low rate (3.1 % after curettage, 0 % after
resection).
Our study has several limitations. First, it is a retro-
spective analysis and not a prospective study, but the rarity
of this pathology and the need for long oncological follow-
up make it difficult to accomplish a prospective study.
Second, comparison of different treatments (curettage
versus wide resection) was not randomized, but on the
basis of current knowledge about this pathology it is not
possible to accomplish a randomized study as different
presentations of the disease suggest specific surgical
choices to avoid undertreatment of locally aggressive
tumors or overtreatment of small and less aggressive
lesions. Third, the follow-up of our patients is significant,
but still too short for definitive considerations about
oncological results.
With the above-mentioned limitations, our experience
confirms that grade 1 chondrosarcoma of the appendicular
skeleton can usually be treated with intralesional curettage
and local adjuvants. Only when aggressive biologic
behavior is evident on imaging (cortical relevant thinning,
enlargement, and/or breakthrough) should wide resection
following surgical principles of malignant bone tumors be
considered.
Considering the very low rate of distant metastases in all
reported series, appropriate oncological follow-up should
be defined to avoid excessive exposure to several CT scans
of the chest, as routinely performed in bone sarcoma.
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